DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more


Nutrilib.com
A comprihensive source of nutritional information

Double Blind Crossover Comparison of Diuretics in the Young

Information source: University of Cambridge
Information obtained from ClinicalTrials.gov on November 03, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Low-Renin Hypertension

Intervention: Bendroflumethiazide 2.5mg - 5mg (Drug); Amiloride 20-40mg (Drug); Spironolactone 50-100mg (Drug); Frusemide 20-40mg (Drug); Bendroflumethiazide 1.25-2.5mg/ Amiloride 10-20mg combined (Drug)

Phase: N/A

Status: Recruiting

Sponsored by: University of Cambridge

Official(s) and/or principal investigator(s):
Morris J Brown, Proffessor, Principal Investigator, Affiliation: Cambridge University

Overall contact:
Morris J Brown, Professor, Phone: 01223 336743, Email: mjb14@medschl.cam.ac.uk

Summary

The principle objective of the study is to determine whether low-renin (i. e. salt sensitive) hypertension at a young age is caused by the kidneys hanging onto too much salt as a result of an over active salt pump in the kidney.

The kidneys have four different salt pumps, and each is blocked by a different type of diuretic (salt losing tablet)If one out of the four is overactive, we would expect patients

to respond much better to one diuretic than to the alternatives - rather than responding

equally well to all available types of diuretic.

Clinical Details

Official title: Double Blind Crossover Comparison od Diuretics in Young Patients With Low Renin Hypertension

Study design: Treatment, Randomized, Double-Blind, Placebo Control, Crossover Assignment, Efficacy Study

Primary outcome:

Difference in systolic blood pressure for subjects' best drug and second best drug.

Difference in plasma renin for subjects' best drug and second best drug.

Secondary outcome: Predictions of best drug

Detailed description: Studies suggest that patients with low renin hypertension respond better to diuretics than other hypertensive drug groups. The aim of the study is to rotate patients through the four main diuretic groups and see if it is possible to identify the most effective diuretic for this group, as measured by a >=10mgHg decrease in Systolic blood pressure in one specific group a compared to the others.

As most caucasians with Low renin hypertension are older (>55), presentation with this type of hypertension at a younger age suggests the presence of substantial genetic variation in order to cause the atypical presentation. It is hoped that by identifying the best diuretic for these patients we will also be able to identify:

1. Whether the young low-renin hypertensives can be sub-classified according to their most effective diuretic;

2. Whether this sub-classification helps us to identify the genes and mutations responsible, since these are to expected to be in the so-called sodium channels (i. e. salt pumps)which the kidneys use to prevent salt being excreted in the urine.

Eligibility

Minimum age: 18 Years. Maximum age: 45 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Aged 18-45

- male or female

- Hypertensive - 3 clinic SBP >=140mmHg; or 3 clinic DBP >=90mmHg; or ABPM or home BP

>=130(SBP) or 85(DBP)

- 24hr Na+<160mmol/l

- EITHER {Plasma renin<=10mU/L (measured untreated, or whilst receiving only

CCB+/-diuretic} + {Plasma renin <=40mU/L (measured on an ACEi or ARB, which approximately double s the plasma renin)} OR Plasma renin <5mU/L (measured untreated, or receiving any antihypertensive drug other than a beta-blocker

Exclusion Criteria:

- Documented history of gout

- Abnormal renal function (both elevated serum creatinine and reduced creatinine

clearance

- SBP > 170mmHg or Diastolic >110mmHg despite treatment with permitted background

treatment

Locations and Contacts

Morris J Brown, Professor, Phone: 01223 336743, Email: mjb14@medschl.cam.ac.uk

University of Cambridge - Addenbrookes Hospital, Cambridge CB2 2QQ, United Kingdom; Recruiting
Morris J Brown, Proffessor, Phone: 01223 336743, Email: mjb14@medschl.cam.uk
Sue Hood, RGN - sister, Sub-Investigator
Diane Picton, RGN- sister, Sub-Investigator
Tim Burton, Phd, MRCP, Sub-Investigator
Additional Information

Starting date: August 2006
Ending date: July 2007
Last updated: January 31, 2007

Page last updated: November 03, 2008

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008